The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Betadine
Povidone-Iodine · POVIDONE-IODINE 5 mg/mL · Spray · Topical · Atlantis Consumer Healthcare, Inc.
NDC 67618-0192-03 · 88.7 mL in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for povidone-iodine (other) in the next 90 days
sole-source market · price up 3% YoY · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- M003
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Povidone-Iodine (Spray)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Atlantis Consumer Healthcare, Inc. | POVIDONE-IODINE 5 mg/mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Betadine — NDC 67618-0192-03," retrieved September 3, 2026, https://drugdashboards.com/drug/67618019203.
Free to cite with attribution — see how the data is put together.